Intensity Therapeutics Director Donovan Daniel Receives Award

What Happened

• Donovan Daniel, a director of Intensity Therapeutics, was granted a derivative award for 5,500 shares on July 16, 2026. The filing lists a price of $0.00 for the award (derivative security), meaning no cash was paid at grant; the award will vest over time rather than representing immediately tradable shares. This is a grant/award (A), not a sale.

Key Details

• Transaction date: 2026-07-16 (reported on Form 4 filed 2026-07-20) — filing appears timely.
• Security: derivative award (described as an option in the footnote) for 5,500 shares; reported price $0.00.
• Vesting: per footnote, the option vests in four equal annual installments beginning July 16, 2026.
• Shares owned after transaction: not specified in the provided filing details.
• No indication of a 10b5-1 plan, tax withholding, cashless exercise, or sale of shares in this filing.

Context

• This is an equity compensation grant (a derivative option award) that vests over time; such awards are common for directors and align long-term incentives but do not constitute an immediate purchase of open-market stock.
• Because the award vests over four years, any potential ownership stake will increase as portions vest and are exercised; intrinsic value depends on Intensity Therapeutics’ future stock price.